Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
| Corporate Authors: | United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, ProQuest (Firm) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Washington :
U.S. G.P.O. :
2001.
|
| Series: | U.S. Congressional Hearings.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Similar Items
Evaluating the effectiveness of the Food and Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
Published: (2001)
Published: (2001)
Pediatric drug research : Food and Drug Administration should more efficiently monitor inclusion of minority children.
Published: (2003)
Published: (2003)
Pediatric drug research : the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2007)
by: Crosse, Marcia
Published: (2007)
Pediatric drug research : substantial increase in studies of drugs for children, but some challenges remain : statement of Janet Heinrich, Director, Health Care--Public Health Issues, [before the] Committee on Health, Education, Labor and Pensions, U.S. Senate /
by: Heinrich, Janet
Published: (2001)
by: Heinrich, Janet
Published: (2001)
Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394).
Published: (2002)
Published: (2002)
The Food and Drug Administration's process for approving new drugs : report /
Published: (1980)
Published: (1980)
FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)
Published: (2002)
The Food and Drug Administration /
by: Patrick, William
Published: (1988)
by: Patrick, William
Published: (1988)
Drug evaluations annual : DE /
Published: (1990)
Published: (1990)
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)
Published: (2005)
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)
Published: (2005)
FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)
Published: (2003)
Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.
Published: (1983)
Published: (1983)
Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)
Published: (1980)
Fundamentals of early clinical drug development : from synthesis design to formulation /
Published: (2006)
Published: (2006)
The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)
Published: (2007)
The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)
Published: (2007)
The pediatric guide to drugs and vitamins /
by: Brace, Edward R.
Published: (1982)
by: Brace, Edward R.
Published: (1982)
Food and Drug Administration : Approval and Oversight of the Drug Mifeprex.
Published: (2008)
Published: (2008)
Pediatric Research Equity Act of 2003 : report together with additional views (to accompany S. 650).
Published: (2003)
Published: (2003)
Best Pharmaceuticals for Children Act : report together with dissenting views (to accompany H.R. 2887) (including cost estimate of the Congressional Budget Office).
Published: (2001)
Published: (2001)
Considering the patient in pediatric drug development : how good intentions turned into harm /
by: Rose, Klaus
Published: (2021)
by: Rose, Klaus
Published: (2021)
Drug responses in man /
Published: (1967)
Published: (1967)
The Food and Drug Administration's process for approving new drugs : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.
Published: (1979)
Published: (1979)
Drug information journal.
Nasal Drug Delivery : Formulations, Developments, Challenges, and Solutions /
Published: (2023)
Published: (2023)
Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.
Published: (1992)
Published: (1992)
Parent & educators' drug reference : a guide to common medical conditions & drugs used in school-aged children /
by: Agins, Alan P.
Published: (1999)
by: Agins, Alan P.
Published: (1999)
Prescription Drugs : FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials.
Published: (2007)
Published: (2007)
Development and evaluation of drugs : from laboratory through licensure to market /
by: Lee, Chi-Jen
Published: (2003)
by: Lee, Chi-Jen
Published: (2003)
Guidance for industry : nonclinical safety evaluation of pediatric drug products.
Published: (2006)
Published: (2006)
Discovery, development, and delivery of new drugs /
by: Beyer, Karl H., 1914-1996
Published: (1978)
by: Beyer, Karl H., 1914-1996
Published: (1978)
FDA's authority to ensure that drugs prescribed to children are safe and effective /
by: Thaul, Susan
Published: (2019)
by: Thaul, Susan
Published: (2019)
Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities.
Published: (2002)
Published: (2002)
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)
Published: (2012)
Drugs : use, misuse, and abuse /
by: Schlaadt, Richard G., 1935-
Published: (1994)
by: Schlaadt, Richard G., 1935-
Published: (1994)
Modern approaches in drug discovery /
Published: (2018)
Published: (2018)
Competitive problems in the drug industry : drug testing : summary and analysis /
Published: (1979)
Published: (1979)
Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)
Published: (2004)
El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)
Published: (2002)